a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...
Scientists have created a new therapeutic approach for testing fragile X syndrome, which is the most common genetic cause of autism ... | Genetics And Genomics ...
A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism spectrum disorder and intellectual disability.
Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.
Boosting NMDA receptor signaling corrected excess protein synthesis in Fragile X model mice. Experimental drug Glyx-13 restored synaptic plasticity and reduced seizures in mice. Findings open the door ...
Exclusive: A world-first Australian study could pave the way for all couples to have free genetic screening before starting a ...
“This year will bring major milestones for Harmony, with the topline data readout from our Phase 3 registrational trial with ZYN002 in Fragile X syndrome expected in Q3 and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback